PNC Financial Services Group Inc. trimmed its position in Bunge Global SA (NYSE:BG – Free Report) by 40.2% in the fourth ...

Monday's transaction, which is expected to be completed in the second quarter of 2025, will add UNLOXCYT, a U.S. FDA-approved treatment for advanced skin cancer, to Sun Pharma's global franchise.

Assetmark Inc. lifted its position in Bunge Global SA (NYSE:BG – Free Report) by 8.3% during the fourth quarter, according to ...

In this article, we are going to take a look at where Bunge Global SA (NYSE:BG) stands against other best depressed stocks to invest in now. The US stocks ended 2024 with a healthy Q4, as the ...

We recently compiled a list of the 10 Worst Farmland and Agriculture Stocks to Buy According to Short Sellers. In this ...

We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at ...

Bunge Global SA (Symbol: BG) has been named as a Top 25 dividend stock, according the most recent Dividend Channel ''DividendRank'' report. The report noted that among the coverage universe ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Bunge Global SA (NYSE:BG) stands against the other cash-rich mid cap stocks. Cash flow is the money moving in and out of a business over a set ...

forecasts 2025 earnings drop U.S. crop commodities trader Bunge Global posted a larger-than-expected quarterly profit drop on Wednesday and warned that 2025 earnings could sink to the lowest in ...